1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > 2014 Sales of Recombinant Therapeutic Antibodies & Proteins

2014 Sales of Recombinant Therapeutic Antibodies & Proteins

  • March 2015
  • -
  • La Merie Publishing
  • -
  • 39 pages

2014 Sales of Recombinant Therapeutic Antibodies & Proteins


This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2014. Sales data were obtained from company publications and refer to branded products originating from companies based in regulated markets. All sales data were converted from their original, published currency into US$ using official currency exchange rates as of March 17, 2015. Sales figures represent the sum of revenues in all territories where the products are marketed and are mostly presented either after hedging.


Sales data are presented for each product within the respective class of biologics. The data were analyzed to establish a ranking list of blockbuster biologics with 2014 sales higher than US$ 1 bln. Another ranking list was prepared for companies according to biologics sales in 2014 and the percentage of antibody sales vs protein sales.


 


Table Of Contents

2014 Sales of Recombinant Therapeutic Antibodies and Proteins

2014 Sales of Recombinant Therapeutic Antibodies andamp; Proteins


Table of Contents:


2014 Biologics Sales per Class of Products

Blockbuster Biologics in 2014 (by generic name)

Company Ranking List for Biologics Sales 2014

Biologic Product Sales 2014

•          Anti-TNF Antibodies

•          Cancer Antibodies

•          Insulin and Insulin Analogs

•          Anti-Inflammatory and Anti-Autoimmune Antibodies

•          Recombinant Coagulation Factors

•          Ophthalmic Antibodies

•          Erythropoietins

•          Interferon beta

•          G-CSF

•          Enzyme Replacement Proteins

•          Human Growth Hormone

•          Interferon alpha

•          Follicle Stimulating Hormone

•          Cardiometabolic andamp; Anti-Infective Antibodies

•          Other Proteins: Cardiometabolic, Cancer andamp; Others


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.